Implantable medical device and computer-implemented method for authorizing remote programming thereof

The implantable medical device integrates a control system to verify patient consent electronically, addressing unauthorized access risks through secure remote programming.

WO2026238464A1PCT designated stage Publication Date: 2026-11-19BIOTRONIK SE & CO KG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2026/062721
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-14
Filing Date
2026-05-04
Publication Date
2026-11-19

Smart Images

  • Figure EP2026062721_19112026_PF_FP_ABST
    Figure EP2026062721_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The invention relates to an implantable medical device (10), comprising at least one therapeutic or diagnostic function that is configurable and / or adjustable by remote programming; and a control system (12) integrated within the implantable medical device (10), said control system (12) being configured to verify that patient consent information (14) authorizing remote programming of the implantable medical device (10) is electronically stored in a data storage unit (16) of the implantable medical device (10). Furthermore, the invention relates to a corresponding computer-implemented method for authorizing remote programming of an implantable medical device (10).
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Applicant: BIOTRONIK SE & Co. KG

[0002] Date: 04.05.2026

[0003] Our Reference: 24.172P-WO

[0004] Implantable medical device and computer-implemented method for authorizing remote programming thereof

[0005] The invention relates to an implantable medical device. Furthermore, the invention relates to a computer-implemented method for authorizing remote programming of an implantable medical device.

[0006] The advancement of implantable medical devices has revolutionized the treatment and management of various medical conditions, particularly in cardiology. Devices such as pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices have become essential for improving patient outcomes by delivering precisely calibrated therapies tailored to the unique needs of individual patients. These devices require frequent programming and reprogramming to optimize their performance, either to adapt to the evolving medical needs of the patient or to align with updated clinical guidelines.

[0007] Traditionally, the programming of implantable medical devices has been carried out in clinical settings. This approach ensures that the attending physician or healthcare professional has access to the necessary diagnostic equipment and can directly observe and assess the patient's condition. However, this traditional model also comes with challenges, particularly for patients who face logistical barriers to attending in-person visits. Patients living in remote areas, those with mobility issues, or those who are immunocompromised may struggle to access the care needed to maintain or update their implantable devices.

[0008] Over recent years, there has been growing interest in leveraging telemedicine technologies to extend the capabilities of implantable medical devices through remote programming. Remote programming allows healthcare professionals to modify device settings from a distance, often using secure online platforms that connect to the implantable device througha communication relay, such as a patient’s home monitoring system or mobile device. This emerging approach has the potential to reduce the need for in-person visits, lower healthcare costs, and provide timely adjustments to device settings, particularly in urgent or critical situations.

[0009] In existing systems, patient consent for remote programming is primarily obtained through non-technical means, such as signed documentation. This consent is typically recorded in the patient’s medical file and serves as a legal acknowledgment of their approval for remote interactions with their implant. However, the consent process is decoupled from the technical operations of the implant itself. The implant does not verify or enforce the presence of consent during a remote programming request. Consequently, there is no built-in mechanism to ensure that programming actions comply with the patient’s expressed preferences.

[0010] Remote programming introduces potential risks of unauthorized access or manipulation. Current systems often rely on basic authentication mechanisms, such as passwords or device serial numbers, to control access. These measures, while functional, are not immune to exploitation, particularly in an era where cybersecurity threats are increasingly sophisticated. Unauthorized access to an implant’s programming interface could lead to unintended or harmful modifications, raising significant safety and privacy concerns.

[0011] It is therefore an object of the present invention to provide a medical implant that ensures remote programming is only performed with the explicit, verifiable consent of the patient.

[0012] The object is solved by an implantable medical device having the features of claim 1.

[0013] Furthermore, the object is solved by a computer-implemented method for authorizing remote programming of an implantable medical device having the features of claim 13.

[0014] Moreover, the object is solved by a computer program having the features of claim 14 and by a computer-readable data carrier having the features of claim 15.

[0015] Further developments and advantageous embodiments are defined in the dependent claims.

[0016] 24.172P-WO / 04.05.2026According to a first aspect, an implantable medical device is provided, comprising:

[0017] at least one therapeutic or diagnostic function that is configurable and / or adjustable by remote programming, and a control system integrated within the implantable medical device, said control system being configured to verify that patient consent information authorizing remote programming of the implantable medical device is electronically stored in a data storage unit of the implantable medical device.

[0018] According to a second aspect, a computer-implemented method for authorizing remote programming of an implantable medical device is provided, comprising the steps of providing an implantable medical device comprising at least one therapeutic or diagnostic function that is configurable and / or adjustable by remote programming; and verifying that patient consent information authorizing remote programming of the implantable medical device is electronically stored in a data storage unit of the implantable medical device.

[0019] The control system integrated within the implantable medical device verifies that patient consent information is stored in the implant through a structured sequence of operations designed to ensure accuracy, authenticity, and compliance with the patient's preferences. First, the control system queries the data storage unit to detect the presence of patient consent information in the designated memory location or parameter. Upon confirming the existence of consent data, it conducts an integrity check, often using cryptographic methods such as hash verification or digital signatures, to ensure that the data has not been tampered with or corrupted.

[0020] Next, the control system validates specific parameters associated with the consent information. This includes checking for a predefined validity duration or expiration timestamp to ensure the consent is still active. If the consent data includes a cryptographic signature, the system uses cryptographic credentials, such as a public key or verification code, to authenticate the stored information and confirm its legitimacy.

[0021] 24.172P-WO / 04.05.2026The control system then cross-references the incoming remote programming request with the stored consent data to verify that the request aligns with the permissions explicitly granted by the patient.

[0022] Finally, based on the results of these checks, the control system determines whether to authorize or reject the remote programming request. If any validation step fails, such as the absence, expiration, or invalidity of consent data, the control system automatically denies the request and generates an error response. This comprehensive process ensures that remote programming is securely tied to verified patient authorization, preventing unauthorized access or unintended modifications to the device.

[0023] The described implantable medical device thus integrates features to ensure secure, controlled, and reliable remote programming. The device comprises at least one therapeutic or diagnostic function that can be adjusted or configured remotely, making it adaptable for various medical applications such as pacemakers, neurostimulators, and defibrillators. By incorporating a control system within the implant itself, the device ensures that remote programming is conducted under strict authorization protocols. The control system is designed to verify the presence of electronically stored patient consent information before allowing any remote programming to occur. This internal verification process creates a self-contained mechanism for managing access to the device’s functionality.

[0024] A further feature of the implant is the use of a dedicated data storage unit within the implant to securely store patient consent information. This ensures that consent data is immediately accessible to the control system for validation during programming attempts. The presence of this data storage unit reduces reliance on external databases or systems, thereby improving the reliability and responsiveness of the device. Furthermore, the use of electronic storage enables integration with cryptographic methods, which can protect the consent information from tampering or unauthorized access. Cryptographic security ensures that only authenticated and approved entities can alter the consent data, enhancing the overall integrity of the system.

[0025] 24.172P-WO / 04.05.2026The computer-implemented method complements the hardware aspects by providing a systematic approach to managing remote programming authorization. The method begins with the provision of an implantable medical device equipped with remote programming capabilities and integrated verification features. This ensures a standard baseline functionality for all devices using this method. The second step involves verifying the presence of patient consent information in the data storage unit. This verification step is automated and embedded into the device’s programming workflow, minimizing human error and streamlining the process.

[0026] By embedding the verification mechanism within the device and method, the system ensures that remote programming actions are aligned with patient preferences. This approach prioritizes patient autonomy and ensures compliance with informed consent practices in medical interventions. Unlike traditional systems that rely on external documentation or manual processes to validate consent, this system directly ties consent to the device’s functionality. This linkage ensures that only authorized programming changes can be made, reducing the risk of unintentional or malicious modifications to the device’s parameters.

[0027] The use of electronically stored consent information introduces additional benefits, particularly in terms of security and operational efficiency. Electronic storage allows for the application of state-of-the-art encryption techniques to safeguard consent data. For example, data can be protected using public-key cryptography, ensuring that only authorized parties can access or modify the stored information. Additionally, the system can include mechanisms for regularly checking the integrity of the stored data, such as hash-based verification. This ensures that the information remains accurate and untampered throughout the device’s operational life.

[0028] The integration of these features into the device’s control system simplifies the overall workflow for remote programming. Healthcare providers no longer need to rely on external systems or complex authentication procedures to confirm consent. Instead, the device itself handles the validation process autonomously, allowing clinicians to focus on the therapeutic aspects of programming rather than administrative tasks. This also reduces the potential for

[0029] 24.172P-WO / 04.05.2026errors or oversights, as the system enforces compliance with consent requirements in a consistent manner.

[0030] The described method also aligns with regulatory requirements for patient safety and data protection. By embedding consent verification directly into the device’s operation, the system provides a robust mechanism for complying with legal and ethical standards. This reduces the burden on healthcare providers and manufacturers to implement external safeguards, as the device itself enforces compliance through its integrated features. Furthermore, the system’s ability to log and document programming attempts provides a traceable record of all interactions with the device, ensuring accountability and transparency.

[0031] In a further aspect, it is proposed that the control system is configured to verify the presence of the patient consent information authorizing remote programming of the implantable medical device upon receipt of a remote programming request.

[0032] This ensures that programming actions are executed only when valid consent is present at the time of the remote programming request. By implementing real-time validation of consent information, unauthorized programming attempts are blocked, reducing security risks. Additionally, the system supports compliance with patient preferences by requiring explicit confirmation before making therapeutic or diagnostic adjustments.

[0033] In a further aspect, it is proposed that the patient consent information stored in the implantable medical device comprises a predefined validity duration, wherein the control system is configured to verify that the patient consent information is valid at the time of receiving the remote programming request.

[0034] This feature prevents outdated consent from being used for programming operations. By associating a validity period with the consent, the system ensures that the patient's authorization remains relevant and up-to-date, enhancing trust and mitigating potential misuse. It also allows for automatic rejection of expired authorizations, streamlining decision-making and maintaining device integrity.

[0035] 24.172P-WO / 04.05.2026In a further aspect, it is proposed that the patient consent information is encrypted using a cryptographic key unique to the implant, in particular an encryption key, a digital certificate, or a verification code.

[0036] Encryption ensures that consent information is stored and transmitted securely, protecting it from unauthorized access or tampering. The use of a unique cryptographic key specific to each implant enhances data security by ensuring that only the designated device and authorized entities can interact with the stored consent data. This approach minimizes risks of data breaches or fraud.

[0037] In a further aspect, it is proposed that the implantable medical device by default is programmed with a unique, non-replicable cryptographic secret.

[0038] A unique cryptographic secret embedded in each implant ensures that programming actions are securely tied to the specific device. This mechanism prevents unauthorized duplication or reuse of programming credentials across devices, improving system security. It also facilitates traceability, as actions can be linked to a specific device for auditing purposes.

[0039] In a further aspect, it is proposed that the implantable medical device is configured to accept storage of the patient consent information in the data storage unit by request of a healthcare or medical professional, if the cryptographic secret, in particular a private key or access code, is provided by a patient to the medical professional.

[0040] This process ensures that patients remain in control of their consent information. By requiring patients to share a cryptographic secret with their medical professional, unauthorized storage of consent or patient consent information is prevented. It also creates a dual -authentication system, where both patient and medical professional participate in securing the programming process.

[0041] In a further aspect, it is proposed that the implantable medical device is configured to accept storage of the patient consent information in the data storage unit upon receipt of the

[0042] 24.172P-WO / 04.05.2026cryptographic secret comprised by an electronic message received from a remote programming system, in particular operated by the medical professional.

[0043] Allowing consent information to be stored via an electronic message ensures secure and remote authorization capabilities. This mechanism provides flexibility for programming the device while maintaining a high level of security through cryptographic validation. It also supports seamless integration with existing remote programming systems, enhancing usability for clinicians.

[0044] In a further aspect, it is proposed that the implantable medical device is configured to receive the patient consent information via a remote programming interface by means of an authentication mechanism usable only by the medical professional.

[0045] Restricting access to the programming interface ensures that only authorized medical professionals can store consent information. By implementing a dedicated authentication mechanism, the system reduces the likelihood of unauthorized access or programming attempts, thereby enhancing the overall safety and reliability of the device.

[0046] In a further aspect, it is proposed that the implantable medical device is configured to receive the patient consent information by an in-office programming device.

[0047] This aspect ensures that consent information can be securely and directly stored in the implant during a controlled clinical interaction. The use of an in-office programming device reduces security risks associated with remote access and ensures accurate programming under the supervision of a medical professional.

[0048] In a further aspect, it is proposed that the implantable medical device is configured to receive the patient consent information through a short-range telemetry interface, in particular near-field communication.

[0049] Short-range telemetry, such as near-field communication, ensures that consent information is transmitted securely and only within a close physical range. This prevents unauthorized

[0050] 24.172P-WO / 04.05.2026remote attempts to store consent data and adds a layer of physical security to the programming process. It also supports convenient and efficient data transfer in clinical settings.

[0051] In a further aspect, it is proposed that the implantable medical device is configured to receive the patient consent information through a patient-operated device, in particular a personal programming controller.

[0052] Allowing patients to use a personal programming controller empowers them to actively participate in the consent process. This feature enhances user autonomy by enabling patients to manage their consent information conveniently. It also integrates seamlessly with patient-operated devices, offering flexibility while maintaining secure interactions.

[0053] In a further aspect, it is proposed that a consent - and thus the patient consent information -is limited to a single programming session or a specific time period ranging from one hour to one day.

[0054] Limiting consent to a single session or a short time frame ensures that authorization is precise and context-specific. This feature minimizes risks associated with prolonged or unintended programming permissions and supports dynamic consent management, aligning the programming process with patient intentions and safety requirements.

[0055] The herein described features of the implantable medical device are also disclosed for the computer-implemented method for authorizing remote programming of an implantable medical device and vice versa.

[0056] For a more complete understanding of the present invention and advantages thereof, reference is now made to the following description taken in conjunction with the accompanying drawings. The invention is explained in more detail below using exemplary embodiments, which are specified in the schematic figures of the drawings, in which:

[0057] 24.172P-WO / 04.05.2026Fig. 1 shows a diagram of an implantable medical device and computer- implemented method for authorizing remote programming thereof according to a preferred embodiment of the invention;

[0058] Fig. 2 shows a diagram of the implantable medical device and computer- implemented method for authorizing remote programming thereof according to the preferred embodiment of the invention; and

[0059] Fig. 3 shows a diagram of the implantable medical device and computer- implemented method for authorizing remote programming thereof according to the preferred embodiment of the invention.

[0060] Fig.l illustrates the initial state of a medical implant system 1 in the absence of patient consent information for remote programming. The diagram depicts an implantable medical device 10, such as a pacemaker, which is connected to a remote programming system 120. The implantable medical device 10 is shown in its default configuration without any patient consent information electronically stored within its internal memory or data storage unit 16.

[0061] In this scenario, a medical professional 130 initiates a remote programming request 140 to the remote programming system 120. The programming request is forwarded / transmitted 150 to the implantable medical device 10, where it is processed by the control system 12 integrated within the implantable medical device 10. The control system 12 verifies whether patient consent information is present in the implantable medical device's 10 data storage unit 16. As no such information exists, the control system 12 rejects the programming request 160 and sends a denial notification back to the medical professional 130.

[0062] This figure highlights the fundamental security mechanism of the system 1, which ensures that programming requests 150 are automatically blocked unless the required consent information has been properly stored within the implantable medical device 10. It emphasizes the device’s built-in safeguards to prevent unauthorized or unintended programming changes, thereby maintaining the integrity and safety of the implantable medical device’s 10 operation.

[0063] 24.172P-WO / 04.05.2026Fig. 2 demonstrates the process of storing patient consent information 14 in the implantable medical device 10. The patient 260 grants their consent to a medical professional 230 and provides a cryptographic secret, such as an access code or digital certificate 270. The cryptographic secret serves as a secure authorization mechanism that ensures only authorized personnel can input the patient consent information 14 into the implantable medical device 10.

[0064] The medical professional 230 uses an in-office programming device 280 to transmit the patient consent information 14, including the cryptographic secret, to the implantable medical device 10 via a secure and controlled interface, such as near-field communication NFC or another short-range telemetry method. The programming device ensures that the consent data with the patent consent information 14 is securely stored in the implantable medical device’s 10 internal memory or data storage unit 16, where it is protected against tampering or unauthorized access.

[0065] Additionally, the diagram indicates the optional step of assigning a validity duration to the patient consent information 14. The patient 260 and the medical professional 230 can agree on a specific time frame during which the patient consent information 14 remains valid, and this duration is also stored within the implantable medical device 10. This ensures that outdated consent information cannot be used for future remote programming requests, providing an additional layer of control and security.

[0066] Fig. 3 depicts the scenario within the system 1, in which the implantable medical device 10 now contains valid patient consent information 14 for remote programming, as stored through the process shown in Fig. 2. The remote programming system 320 communicates with the implantable medical device 10 under the direction of a medical professional 330.

[0067] When the medical professional 330 initiates a programming request 340, it is forwarded / transmitted 350 to the implantable medical device 10, where the control system 12 verifies the presence and validity of the stored patient consent information 14. Since the consent data with the patent consent information 14 is valid and active, the control system

[0068] 24.172P-WO / 04.05.202612 authorizes the requested programming changes, enabling the adjustment or configuration of the implantable medical device’s 10 therapeutic or diagnostic functions. The approval of the remote programming request 350 is also communicated back to the medical professional 330, completing the process.

[0069] This figure highlights the ability of the system 1 to securely and efficiently process remote programming requests when proper authorization is in place. By ensuring that only remote programming requests supported by valid patient consent information 14 are accepted, the implantable medical device 10 maintains a high level of security and aligns its functionality with patient preferences and safety standards.

[0070] Although specific embodiments have been illustrated and described herein, it will be understood by those skilled in the art that a variety of alternative and / or equivalent implementations exist. It should be noted that the exemplary embodiment or exemplary embodiments are examples only and are not intended to limit the scope, applicability or configuration in any way.

[0071] Rather, the foregoing detailed description provides the skilled person with a convenient guide to implementing at least one exemplary embodiment, it being understood that various changes in the scope of functionality and arrangement of the elements may be made without departing from the scope of the appended claims and their legal equivalents.

[0072] In general, this application intends to cover modifications or adaptations or variations of the embodiments disclosed herein. For example, a sequence of method steps may be modified. The method may further be carried out sequentially or in parallel, at least in part.

[0073] 24.172P-WO / 04.05.2026Reference Signs

[0074] 1 system

[0075] 10 implantable medical device

[0076] 12 control system

[0077] 14 patient consent information

[0078] 16 data storage unit

[0079] 120, 320 remote programming system

[0080] 130, 230, 330 medical professional

[0081] 140, 150, 340, 350 remote programming request

[0082] 160 rejection of remote programming request 260 patient

[0083] 270 access code or digital certificate 280 an in-office programming device S1 - S2 method steps

[0084] 24.172P-WO / 04.05.2026

Claims

Claims1. Implantable medical device (10), comprising:at least one therapeutic or diagnostic function that is configurable and / or adjustable by remote programming; anda control system (12) integrated within the implantable medical device (10), said control system (12) being configured to verify that patient consent information (14) authorizing remote programming of the implantable medical device (10) is electronically stored in a data storage unit (16) of the implantable medical device (10).

2. Implantable medical device of claim 1, wherein the control system (12) is configured to verify the presence of the patient consent information (14) authorizing remote programming of the implantable medical device (10) upon receipt of a remote programming request (150, 350).

3. Implantable medical device of claim 2, wherein the patient consent information (14) stored in the implantable medical device (10) comprises a predefined validity duration, wherein the control system (12) is configured to verify that the patient consent information (14) is valid at the time of receiving the remote programming request (150, 350).

4. Implantable medical device of any one of the preceding claims, wherein the patient consent information (14) is encrypted using a cryptographic key unique to the implant, in particular an encryption key, a digital certificate (270), or a verification code.

5. Implantable medical device of any one of the preceding claims, wherein the implantable medical device (10) by default is programmed with a unique, non- replicable cryptographic secret.

6. Implantable medical device of claim 5, wherein the implantable medical device (10) is configured to accept storage of the patient consent information (14) in the data storage unit (16) by request of a medical professional (130, 230, 330), if the24.172P-WO / 04.05.2026cryptographic secret, in particular a private key or access code (270), is provided by a patient (260) to the medical professional (130, 230, 330).

7. Implantable medical device of claim 5 or 6, wherein the implantable medical device (10) is configured to accept storage of the patient consent information (14) in the data storage unit (16) upon receipt of the cryptographic secret comprised by an electronic message received from a remote programming system (120, 320), in particular operated by the medical professional (130, 230, 330).

8. Implantable medical device of any one of claims 1 to 7, wherein the implantable medical device (10) is configured to receive the patient consent information (14) via a remote programming interface by means of an authentication mechanism usable only by the medical professional (130, 230, 330).

9. Implantable medical device of any one of claims 1 to 7, wherein the implantable medical device (10) is configured to receive the patient consent information (14) by an in-office programming device (280).

10. Implantable medical device of any one of claims 1 to 7, wherein the implantable medical device (10) is configured to receive the patient consent information (14) through a short-range telemetry interface, in particular near-field communication.

11. Implantable medical device of any one of claims 1 to 7, wherein the implantable medical device (10) is configured to receive the patient consent information (14) through a patient-operated device, in particular a personal programming controller.

12. Implantable medical device of claim 11, wherein the patient consent information 14 is limited to a single programming session or a specific time period ranging from one hour to one day.

13. Computer-implemented method for authorizing remote programming of an implantable medical device (10), comprising the steps of:24.172P-WO / 04.05.2026providing (SI) an implantable medical device (10) comprising at least one therapeutic or diagnostic function that is configurable and / or adjustable by remote programming; andverifying (S2) that patient consent information (14) authorizing remote programming of the implantable medical device (10) is electronically stored in a data storage unit (16) of the implantable medical device (10).

14. Computer program with program code to perform the method of claim 13 when the computer program is executed on a computer.

15. Computer-readable data carrier containing program code of a computer program for performing the method of claim 13 when the computer program is executed on a computer.24.172P-WO / 04.05.2026